Exploring risks of investor claims brought forth after the TRIPS waiver for COVID-19
{{output}}
This research plans to explore the risks of the investment claims involved in the ongoing technology transfers to COVID-19 vaccine manufacturers based on the recently approved 'Agreement on Trade-Related Aspects of Intellectual Property Rights' (TRIPS) waiver.... ...
